Andere Sprachen Revvity, Inc.

Aktien

850943

US7140461093

RVTY

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 28.05.2024			% 5 Tage	% 1. Jan.
111,9 ^USD	-1,24 %		-1,21 %	+2,33 %

14.05.	Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM
30.04.	REVVITY, INC. : Bewertung von TD Cowen kaufen	ZM

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Revvity to Present at Goldman Sachs Global Healthcare Conference	28.05.
Revvity : Q1 2024 Earnings Transcript	30.04.
Revvity beats quarterly estimates on demand for diagnostic equipment	29.04.
Revvity Q1 Adjusted Earnings, Revenue Down; Lowers 2024 Revenue Guidance	29.04.
Earnings Flash (RVTY) REVVITY Reports Q1 Revenue $649.9M, vs. Street Est of $647.5M	29.04.
Revvity: Q1 Earnings Snapshot	29.04.
Earnings Flash (RVTY) REVVITY Posts Q1 EPS $0.98, vs. Street Est of $0.94	29.04.
Revvity Announces Financial Results for the First Quarter of 2024	29.04.
Revvity, Inc. Updates Earnings Guidance for the Full Year 2024	29.04.
Revvity, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29.04.
Revvity Board Declares Quarterly Dividend	25.04.
Revvity, Inc. Declares Quarterly Dividend, Payable on August 9, 2024	25.04.
Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings	25.04.
Revvity to Present at BofA Securities 2024 Health Care Conference	25.04.
Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing	25.04.
Declaration of Voting Results by Revvity, Inc	24.04.
Revvity Unveils a New Era of Automated Tuberculosis Testing	24.04.
Revvity Unveils A New Era of Automated Tuberculosis Testing	24.04.
Revvity Signals Software's New Synergy Solution Redefines Collaboration between Pharma and Contract Partners	16.04.
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners	15.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Revvity, Inc.

Aktien

850943

US7140461093

RVTY

Andere Sprachen

Filter